Celltrion’s Vegzelma overtakes Roche’s Avastin in Europe
Celltrion’s metastatic colorectal and breast cancer treatment Vegzelma (bevacizumab) has surpassed Roche’s original drug Avastin, becoming the most…
Celltrion
22 개의 기사가 있습니다.
Celltrion Secures First Approval for Prolia Biosimilar in Korea
Celltrion has received its first approval for a biosimilar of Prolia (denosumab), a treatment for osteoporosis. On the…
Celltrion Acquires Swiss Pharmaceutical Distributor, iQone Healthcare Switzerland
Celltrion announced on the 15th that it has acquired the Swiss pharmaceutical distribution company "iQone Healthcare Switzerland." The…
Celltrion Establishes Subsidiary in Vietnam
Celltrion has officially entered the ASEAN market by establishing a local subsidiary in Vietnam. Following the company's tradition…
Celltrion Launches Zymfentra Media Campaign in the U.S.
Celltrion announced on the 27th that it has launched a media campaign in the U.S. for "Zymfentra," the…
12 Healthcare Stocks Including Celltrion Added to K-Value Up Index
The government has selected the ‘Korea Value Up’ Index as part of its efforts to address the Korea…
Celltrion Signs Contract with Major U.S. Insurer Cigna to List 'Zymfentra'
Celltrion has signed a listing agreement for Zymfentra with the major U.S. insurer Cigna, following its successful agreements…
Celltrion Receives FDA Approval for Phase 3 Clinical Trial of Keytruda Biosimilar in the U.S.
Celltrion announced on the 12th that it has received approval from the U.S. Food and Drug Administration (FDA)…
Celltrion's 'Zymfentra' Listed by Big Three PBMs
Celltrion's 'Zymfentra', has been successfully listed in the formularies of all three major Pharmacy Benefit Managers (or PBMs)…
Why Celltrion’s Retail Investors Oppose the Merger with Celltrion Pharm
“60,000 Celltrion shareholders firmly oppose the merger with Celltrion Pharm, which undermines shareholder value. We strongly urge the…